Interleukin-36γ aggravates macrophage foam cell formation and atherosclerosis progression in ApoE knockout mice

Minghua Zhang1, Jing Liu2, Rong Gao3

  • 1Clinical Pharmacy Laboratory, Chinese PLA General Hospital, Beijing 100853, China.

Cytokine
|July 10, 2021
PubMed

Insights

Interleukin-36 gamma (IL-36γ) promotes atherosclerosis by increasing macrophage foam cell formation. This involves upregulating CD36 scavenger receptor expression via the phosphoinositide 3-kinase pathway, highlighting IL-36γ as a key factor in this cardiovascular disease.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Molecular Biology

Background:

  • Atherosclerosis is a leading global cause of mortality.
  • Macrophage foam cell formation is a critical early step in atherogenesis.
  • The precise molecular mechanisms driving foam cell formation require further elucidation.

Purpose of the Study:

  • To investigate the role of Interleukin-36 gamma (IL-36γ) in atherosclerosis pathogenesis.
  • To explore how IL-36γ influences macrophage inflammatory and metabolic processes.

Main Methods:

  • Studied the effects of IL-36γ on macrophage inflammatory responses and lipoprotein metabolism.
  • Investigated IL-36γ's impact on oxidized low-density lipoprotein uptake and foam cell formation.
  • Examined the molecular pathways, including the phosphoinositide 3-kinase pathway and CD36 expression, regulated by IL-36γ in macrophages.

Main Results:

  • IL-36γ was found to regulate inflammatory responses and lipoprotein metabolism in macrophages.
  • IL-36γ promotes atherosclerosis by enhancing macrophage foam cell formation.
  • IL-36γ upregulates scavenger receptor CD36 expression via the phosphoinositide 3-kinase pathway in macrophages.

Conclusions:

  • IL-36γ is a novel regulator of macrophage foam cell formation.
  • IL-36γ plays a significant role in the progression of atherosclerosis.
  • Targeting IL-36γ pathways may offer therapeutic strategies for atherosclerosis.